Utilization of Patient-Reported Outcomes to Guide Symptom Management during Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer
IntroductionUtilization of patient-reported outcomes (PROs) to guide symptom management during radiation therapy is increasing. This study focuses on the use of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) as a tool to assess urinary and bowel bother during stereotact...
Main Authors: | Malika Danner, Ming-yang Hung, Thomas M. Yung, Marilyn Ayoob, Siyuan Lei, Brian T. Collins, Simeng Suy, Sean P. Collins |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00227/full |
Similar Items
-
Stereotactic body radiation therapy for low- and low-intermediate risk prostate cancer: Is there a dose effect?
by: Alan Jay Katz, et al.
Published: (2011-12-01) -
Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer
by: Einsley-Marie eJanowski, et al.
Published: (2015-07-01) -
Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)
by: Abigail Pepin, et al.
Published: (2020-05-01) -
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer
by: Jennifer Ai-Lian Woo, et al.
Published: (2014-05-01) -
Improved irritative voiding symptoms three years after stereotactic body radiation therapy for prostate cancer.
by: Zakie eRana, et al.
Published: (2014-10-01)